Enhanced	enhanced	O	O
stimulus-induced	stimulus-induced	O	O
neurotransmitter	neurotransmitter	O	O
overflow	overflow	O	O
in	in	O	O
epinephrine-induced	epinephrine-induced	O	O
hypertensive	hypertensive	O	S_disease
rats	rats	O	O
is	is	O	O
not	not	O	O
mediated	mediated	O	O
by	by	O	O
prejunctional	prejunctional	O	O
beta-adrenoceptor	beta-adrenoceptor	O	O
activation	activation	O	O
.	.	O	O

The	the	O	O
present	present	O	O
study	study	O	O
examines	examines	O	O
the	the	O	O
effect	effect	O	O
of	of	O	O
6-day	6-day	O	O
epinephrine	epinephrine	S_chemical	O
treatment	treatment	O	O
(	(	O	O
100	100	O	O
micrograms/kg	micrograms/kg	O	O
per	per	O	O
h	h	S_chemical	O
,	,	O	O
s.c	s.c	O	O
.	.	O	O
)	)	O	O
on	on	O	O
stimulus-induced	stimulus-induced	O	O
(	(	O	O
1	1	O	O
Hz	hz	O	O
)	)	O	O
endogenous	endogenous	O	O
neurotransmitter	neurotransmitter	O	O
overflow	overflow	O	O
from	from	O	O
the	the	O	O
isolated	isolated	O	O
perfused	perfused	O	O
kidney	kidney	O	O
of	of	O	O
vehicle-	vehicle-	O	O
and	and	O	O
epinephrine-treated	epinephrine-treated	O	O
rats	rats	O	O
.	.	O	O

Renal	renal	O	O
catecholamine	catecholamine	S_chemical	O
stores	stores	O	O
and	and	O	O
stimulus-induced	stimulus-induced	O	O
overflow	overflow	O	O
in	in	O	O
the	the	O	O
vehicle-treated	vehicle-treated	O	O
group	group	O	O
consisted	consisted	O	O
of	of	O	O
norepinephrine	norepinephrine	S_chemical	O
only	only	O	O
.	.	O	O

However	however	O	O
,	,	O	O
epinephrine	epinephrine	S_chemical	O
treatment	treatment	O	O
resulted	resulted	O	O
in	in	O	O
the	the	O	O
incorporation	incorporation	O	O
of	of	O	O
epinephrine	epinephrine	S_chemical	O
into	into	O	O
renal	renal	O	O
catecholamine	catecholamine	S_chemical	O
stores	stores	O	O
such	such	O	O
that	that	O	O
approximately	approximately	O	O
40	40	O	O
%	%	O	O
of	of	O	O
the	the	O	O
catecholamine	catecholamine	S_chemical	O
present	present	O	O
was	was	O	O
epinephrine	epinephrine	S_chemical	O
while	while	O	O
the	the	O	O
norepinephrine	norepinephrine	S_chemical	O
content	content	O	O
was	was	O	O
reduced	reduced	O	O
by	by	O	O
a	a	O	O
similar	similar	O	O
degree	degree	O	O
.	.	O	O

Total	total	O	O
tissue	tissue	O	O
catecholamine	catecholamine	S_chemical	O
content	content	O	O
of	of	O	O
the	the	O	O
kidney	kidney	O	O
on	on	O	O
a	a	O	O
molar	molar	O	O
basis	basis	O	O
was	was	O	O
unchanged	unchanged	O	O
.	.	O	O

Stimulus-induced	stimulus-induced	O	O
fractional	fractional	O	O
overflow	overflow	O	O
of	of	O	O
neurotransmitter	neurotransmitter	O	O
from	from	O	O
the	the	O	O
epinephrine-treated	epinephrine-treated	O	O
kidneys	kidneys	O	O
was	was	O	O
approximately	approximately	O	O
twice	twice	O	O
normal	normal	O	O
and	and	O	O
consisted	consisted	O	O
of	of	O	O
both	both	O	O
norepinephrine	norepinephrine	S_chemical	O
and	and	O	O
epinephrine	epinephrine	S_chemical	O
in	in	O	O
proportions	proportions	O	O
similar	similar	O	O
to	to	O	O
those	those	O	O
found	found	O	O
in	in	O	O
the	the	O	O
kidney	kidney	O	O
.	.	O	O

This	this	O	O
difference	difference	O	O
in	in	O	O
fractional	fractional	O	O
overflow	overflow	O	O
between	between	O	O
groups	groups	O	O
was	was	O	O
not	not	O	O
affected	affected	O	O
by	by	O	O
neuronal	neuronal	O	O
and	and	O	O
extraneuronal	extraneuronal	O	O
uptake	uptake	O	O
blockade	blockade	O	O
.	.	O	O

Propranolol	propranolol	S_chemical	O
had	had	O	O
no	no	O	O
effect	effect	O	O
on	on	O	O
stimulus-induced	stimulus-induced	O	O
overflow	overflow	O	O
in	in	O	O
either	either	O	O
group	group	O	O
.	.	O	O

Phentolamine	phentolamine	O	O
increased	increased	O	O
stimulus-induced	stimulus-induced	O	O
overflow	overflow	O	O
in	in	O	O
both	both	O	O
groups	groups	O	O
although	although	O	O
the	the	O	O
increment	increment	O	O
in	in	O	O
overflow	overflow	O	O
was	was	O	O
greater	greater	O	O
in	in	O	O
the	the	O	O
epinephrine-treated	epinephrine-treated	O	O
group	group	O	O
.	.	O	O

In	in	O	O
conclusion	conclusion	O	O
,	,	O	O
chronic	chronic	O	O
epinephrine	epinephrine	S_chemical	O
treatment	treatment	O	O
results	results	O	O
in	in	O	O
enhanced	enhanced	O	O
fractional	fractional	O	O
neurotransmitter	neurotransmitter	O	O
overflow	overflow	O	O
.	.	O	O

However	however	O	O
,	,	O	O
neither	neither	O	O
alterations	alterations	O	O
in	in	O	O
prejunctional	prejunctional	O	O
beta-adrenoceptor	beta-adrenoceptor	O	O
influences	influences	O	O
nor	nor	O	O
alterations	alterations	O	O
in	in	O	O
neuronal	neuronal	O	O
and	and	O	O
extraneuronal	extraneuronal	O	O
uptake	uptake	O	O
mechanisms	mechanisms	O	O
appear	appear	O	O
to	to	O	O
be	be	O	O
responsible	responsible	O	O
for	for	O	O
this	this	O	O
alteration	alteration	O	O
.	.	O	O

Furthermore	furthermore	O	O
,	,	O	O
data	data	O	O
obtained	obtained	O	O
with	with	O	O
phentolamine	phentolamine	O	O
alone	alone	O	O
do	do	O	O
not	not	O	O
suggest	suggest	O	O
alpha-adrenoceptor	alpha-adrenoceptor	O	O
desensitization	desensitization	O	O
as	as	O	O
the	the	O	O
cause	cause	O	O
of	of	O	O
the	the	O	O
enhanced	enhanced	O	O
neurotransmitter	neurotransmitter	O	O
overflow	overflow	O	O
after	after	O	O
epinephrine	epinephrine	S_chemical	O
treatment	treatment	O	O
.	.	O	O

